Susquehanna International Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Buy |
150,744
+140,091
| +1,315% | +$1.34M | ﹤0.01% | 7272 |
|
|
2025
Q4 | $129K | Sell |
10,653
-628,299
| -98% | -$7.63M | ﹤0.01% | 11291 |
|
|
2025
Q3 | $7.47M | Sell |
638,952
-1,149,651
| -64% | -$13.7M | 0.01% | 3447 |
|
|
2025
Q2 | $16.6M | Buy |
1,788,603
+1,349,159
| +307% | +$10.6M | 0.03% | 2204 |
|
|
2025
Q1 | $3.22M | Buy |
439,444
+327,707
| +293% | +$2.52M | 0.01% | 4513 |
|
|
2024
Q4 | $954K | Buy |
111,737
+43,089
| +63% | +$420K | ﹤0.01% | 7070 |
|
|
2024
Q3 | $597K | Sell |
68,648
-10,220
| -13% | -$84.2K | ﹤0.01% | 8045 |
|
|
2024
Q2 | $539K | Sell |
78,868
-116,649
| -60% | -$720K | ﹤0.01% | 8083 |
|
|
2024
Q1 | $1.78M | Buy |
195,517
+87,870
| +82% | +$624K | ﹤0.01% | 5612 |
|
|
2023
Q4 | $480K | Buy |
107,647
+43,117
| +67% | +$128K | ﹤0.01% | 8769 |
|
|
2023
Q3 | $203K | Sell |
64,530
-311,071
| -83% | -$1.27M | ﹤0.01% | 10204 |
|
|
2023
Q2 | $1.94M | Buy |
375,601
+131,022
| +54% | +$779K | ﹤0.01% | 5219 |
|
|
2023
Q1 | $1.29M | Buy |
244,579
+112,283
| +85% | +$533K | ﹤0.01% | 6174 |
|
|
2022
Q4 | $372K | Sell |
132,296
-164,409
| -55% | -$544K | ﹤0.01% | 8590 |
|
|
2022
Q3 | $1.23M | Buy |
296,705
+263,385
| +790% | +$1.33M | ﹤0.01% | 6105 |
|
|
2022
Q2 | $134K | Sell |
33,320
-28,407
| -46% | -$107K | ﹤0.01% | 11168 |
|
|
2022
Q1 | $306K | Sell |
61,727
-143,760
| -70% | -$797K | ﹤0.01% | 10235 |
|
|
2021
Q4 | $1.43M | Buy |
+205,487
| New | +$1.6M | ﹤0.01% | 6318 |
|
|
2021
Q3 | – | Sell |
-247,270
| Closed | -$2.78M | – | 13469 |
|
|
2021
Q2 | $3.51M | Sell |
247,270
-9,753
| -4% | -$148K | ﹤0.01% | 4704 |
|
|
2021
Q1 | $4.22M | Buy |
257,023
+77,063
| +43% | +$1.48M | 0.01% | 4234 |
|
|
2020
Q4 | $3.73M | Buy |
179,960
+42,120
| +31% | +$626K | 0.01% | 3934 |
|
|
2020
Q3 | $1.05M | Sell |
137,840
-10,598
| -7% | -$88K | ﹤0.01% | 6007 |
|
|
2020
Q2 | $1.24M | Buy |
148,438
+135,577
| +1,054% | +$899K | ﹤0.01% | 5430 |
|
|
2020
Q1 | $64K | Sell |
12,861
-148,271
| -92% | -$732K | ﹤0.01% | 9564 |
|
|
2019
Q4 | $636K | Buy |
161,132
+55,397
| +52% | +$193K | ﹤0.01% | 6466 |
|
|
2019
Q3 | $321K | Sell |
105,735
-65,660
| -38% | -$294K | ﹤0.01% | 8158 |
|
|
2019
Q2 | $754K | Buy |
+171,395
| New | +$634K | ﹤0.01% | 6330 |
|
|
2019
Q1 | – | Sell |
-62,614
| Closed | -$252K | – | 10012 |
|
|
2018
Q4 | $249K | Buy |
62,614
+14,185
| +29% | +$78.2K | ﹤0.01% | 7352 |
|
|
2018
Q3 | $333K | Sell |
48,429
-7,243
| -13% | -$45.5K | ﹤0.01% | 7286 |
|
|
2018
Q2 | $375K | Buy |
+55,672
| New | +$382K | ﹤0.01% | 7401 |
|
|
2018
Q1 | – | Sell |
-49,202
| Closed | -$277K | – | 10256 |
|
|
2017
Q4 | $219K | Buy |
49,202
+38,405
| +356% | +$196K | ﹤0.01% | 8113 |
|
|
2017
Q3 | $67K | Sell |
10,797
-48,180
| -82% | -$310K | ﹤0.01% | 8472 |
|
|
2017
Q2 | $547K | Buy |
+58,977
| New | +$571K | ﹤0.01% | 6482 |
|
|
2017
Q1 | – | Sell |
-72,685
| Closed | -$605K | – | 9855 |
|
|
2016
Q4 | $608K | Buy |
+72,685
| New | +$564K | ﹤0.01% | 6579 |
|
|
2016
Q1 | – | Sell |
-12,155
| Closed | -$92.1K | – | 9556 |
|
|
2015
Q4 | $114K | Buy |
+12,155
| New | +$131K | ﹤0.01% | 8817 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
